Concepedia

Myron Chu

MC

Statistics

Publications

11

Citations

523

H-Index

11

Active since

2013

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Age UK

University of Occupational and Environmental Health Japan

Chinese Academy of Medical Sciences & Peking Union Medical College

Myron Chu is an author at GlaxoSmithKline (United States) specializing in dermatology, autoimmune disease, and medicine.

ORCID

Top concepts

Publications per year

2013–2025

11

Publications

11

A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea

Fengchun Zhang, Sang‐Cheol Bae, Damon Bass et al. · Annals of the Rheumatic Diseases · 2018 · 277 citations · Full text

Epidemiology and Treatment of New‐Onset and Established Rheumatoid Arthritis in an Insured US Population

Martin M. Crane, Maneesh Juneja, Jeffery K. Allen et al. · Arthritis Care & Research · 2015 · 48 citations

Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/II Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Regina Kurrasch, Judith C. Brown, Myron Chu et al. · The Journal of Rheumatology · 2013 · 44 citations · Full text

Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

David Fiorentino, Aaron R. Mangold, Victoria P. Werth et al. · The Lancet · 2025 · 36 citations

, , +7

Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials

Emilia Quattrocchi, Mikkel Østergaard, Peter C. Taylor et al. · PLoS ONE · 2016 · 26 citations · Full text

1–5 of 11